Home | Add Company | Subscribe | Search | Contact





Add Company

Your company can benefit from enhanced listings. Questions? Read our FAQ first.


Personalized notification service and newsletter info

Subscribe (free) to get notified of new additions.


Learn more About us and about our Services


Contact us


First-to-market EU registration dossier

Offer available for: licensing

Pharmaceutical form and dosage: 10 mg Tablets


- Generics
- Pharmaceuticals / Therapeutics
- Prescription drugs (Rx)

Therapeutic target:

- Central nervous system
- Neurology

Action: Psycholeptics (CNS)

Company Contact

Corporate data: PharmaRegistrations

Contact for this offer: Lieve Vermassen

Or check this company's:

Full Description:
Zolpidem dossier:
-New dossier available for licensing
-Marketing Authorization to be obtained soon (we can also register requested other countries)
-Stability: 25C: 18 months + continued, 40C: 6 months

Availability and Market information:

Status: Registration

Market(s) and Registration Info: (date: concerns Marketing Authorization)
- Denmark
Registration info: Registration in several countries possible
BE available

Market information

Other Market Info:

Patent Information:
Name: Stilnoct
Patent expiration date: 2002
Patent info: Development of pharmaceuticals which are still under patent is carried out according to EU-requirements in countries with no existing patents or with Bolar-provisions.
We deliver to all countries where the substance and its use are not protected by patents.

Suggestion box | Disclaimer | Privacy Policy | Rules & Regulations
Copyright© Cofidei, Inc. Page Last modified: 15-Jan-2002.

Home | Add Company | Subscribe to Newsletter | Search Companies | Search Offers | Power search